ClinicalTrials.gov
public full text
Public Domain
Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ#1101504
- Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma#217028
- Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC#848178
- A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma#918121
- Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer#834513
Record · ID 307461
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive